OBX
Obsidian Therapeutics, Inc.
Company overview
- Market capitalization
- $825.90M
- Employees
- —
- Latest publication
- 2026-09-29
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Research Development | 15,732,000USD |
| Total Operating Expenses | 20,280,000USD |
| Net Income | -19,633,000USD |
| Source | DisclosurePreliminary |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Total Assets | 0USD |
| Total Current Assets | 0USD |
| Other Non Current Assets | 0USD |
| Total Liabilities | 0USD |
| Total Current Liabilities | 0USD |
| Other Non Current Liabilities | 0USD |
| Total Stockholder Equity | 0USD |
| Total Equity Including Noncontrolling Interest | 0USD |
| Common Stock | 0USD |
| Retained Earnings | 0USD |
| Accumulated Other Comprehensive Income | 0USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Operating Cash Flow | 0USD |
| Investing Cash Flow | 0USD |
| Financing Cash Flow | 0USD |
| Change In Cash | 0USD |
| End Cash Flow | 0USD |
| Source | DisclosureDeterministicFinal |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.